Index
Biostimulators — also called collagen boosters — stimulate the body’s own collagen production rather than adding volume directly.
Two of the most commonly discussed options are Juvelook (PDLLA) and Ellansé (PCL).
They share a category but differ significantly in mechanism, onset, and duration.
At 4Ever Cheongdam Clinic, Dr. Younghan Seo clarifies the distinction and outlines when each is the more appropriate clinical choice.
Key Takeaways
Biostimulators differ from skin boosters: they induce structural collagen production rather than adding hydration or volume directly.
Juvelook (PDLLA) produces gradual, natural-looking collagen accumulation over six to eight months before requiring retreatment.
Ellansé (PCL) delivers both immediate volumetric effect and sustained collagen induction lasting one to three years depending on formulation.
For patients with generalized volume loss, combining Teoxane RHA4 filler with Thermage FLX provides structural support alongside SMAS-layer reinforcement.
Product selection matters less than the injector’s anatomical knowledge and clinical experience — both products carry risk of under- or over-correction if misapplied.
What Is a Biostimulator?
The term “collagen booster” remains in common use, but the clinical classification is biostimulator — a substance that stimulates the body’s own tissue to generate new collagen rather than supplying it externally.
The distinction from skin boosters is functional: skin boosters deliver hydration and nutritional support directly into the dermis.
Biostimulators trigger a biological response within the tissue itself, producing structural collagen over weeks to months.
The improvement is gradual, but the result reflects the body’s own regenerative output rather than an introduced material.
Primary biostimulators include Juvelook (PDLLA), Ellansé (PCL), Sculptra (PLLA), and Radiesse (CaHA), each differing in particle structure, degradation timeline, and collagen induction intensity.
Juvelook vs. Ellansé: Clinical Comparison
Juvelook (PDLLA)
Juvelook contains poly-D,L-lactic acid (PDLLA) microparticles that create localized tissue stimulation upon injection into the dermis and subcutaneous layer.
As PDLLA particles degrade, they trigger surrounding fibroblasts to produce new collagen.
The result is a gradual, progressive improvement in skin density and texture over several weeks.
The collagen response is relatively mild compared to PCL-based products, which makes Juvelook better suited to patients who want subtle, incremental change rather than pronounced structural correction.
Duration averages six to eight months, making periodic retreatment necessary for maintained results.
For patients who are new to biostimulators or who have reactive skin, Juvelook’s gentler stimulus profile is a relevant clinical advantage.
Ellansé (PCL)
Ellansé uses polycaprolactone (PCL), a larger and denser particle than PDLLA.
The greater particle mass produces a stronger collagen induction signal and remains in tissue longer before degrading, extending both the duration and intensity of the collagen response.
Ellansé is available in two formulations approved in Korea:
Ellansé S reinforces dermal density and addresses surface laxity.
It is suited to patients with thin or structurally weakened skin presenting with fine lines and early volume deflation. Duration is approximately one year, making it a practical entry point.
Ellansé M uses a longer PCL chain, extending collagen induction and product longevity to two to three years from a single session.
Clinical cases have confirmed active collagen formation at the two-year mark.
Ellansé also provides immediate volumetric correction as the carrier gel fills the treated area — a property Juvelook does not share.
This dual mechanism (immediate volume + sustained collagen induction) makes it functionally distinct from other biostimulators.
The trade-off is that stronger stimulus requires more precise placement.
Over-injection or incorrect anatomical targeting risks localized overstimulation. Ellansé demands more from the injector than products with a milder collagen response.
When to Add Filler and Thermage FLX
For patients presenting with generalized volume deflation across multiple facial zones, biostimulator monotherapy may be insufficient as a starting point.
In these cases, combining Teoxane RHA4 filler with a biostimulator provides immediate structural support while collagen induction develops over subsequent weeks.
Teoxane RHA4’s high viscoelasticity and cohesive structure make it appropriate for areas requiring load-bearing volumetric support.
Dr. Seo holds Teoxane Country Expert designation and attended Teoxane Academy Day Asia 2025 as a Korean representative.
When retaining ligament laxity is also present — causing injected volume to migrate inferiorly over time — adding Thermage FLX reinforces the SMAS layer and supporting ligaments, improving both the stability and longevity of the injectable result.
Thermage also provides an independent collagen stimulus that complements biostimulator activity.
Why Clinical Experience Matters More Than Product Selection
The more consequential decision is not which biostimulator to use but who administers it. Both Juvelook and Ellansé carry distinct risks when misapplied:
Juvelook under-dosed produces minimal effect; patients may undergo unnecessary repeat sessions without meaningful improvement.
Ellansé over-injected or placed incorrectly risks localized nodule formation or tissue overstimulation, as PCL’s strong collagen response does not self-correct.
Appropriate product selection, dosing, and anatomical placement require deep familiarity with facial tissue architecture and significant biostimulator-specific clinical experience.
These are the variables that determine outcome quality, not the product name alone.
About 4Ever Cheongdam Clinic
4Ever Cheongdam Clinic is a dermatology practice in Cheongdam-dong, Seoul, South Korea.
Dr. Younghan Seo holds KOL designation with Sinclair Pharmaceuticals for Ellansé and Teoxane Country Expert designation for the RHA filler line.
He presents regularly at Korean academic aesthetic medicine conferences and conducts practitioner education on injectable protocols.
Consultations assess tissue volume, structural laxity, and collagen status before any biostimulator protocol is finalized.
Frequently Asked Questions
Q. How long do Juvelook and Ellansé results last, and how often is retreatment needed?
A. Juvelook results last an average of six to eight months, after which retreatment is recommended to maintain collagen density. Ellansé S lasts approximately one year; Ellansé M sustains collagen induction for two to three years from a single session. Retreatment timing is assessed individually based on clinical response at follow-up.
Q. Are biostimulators safe, and what are the main risks?
A. Both Juvelook and Ellansé carry established safety profiles when administered by experienced physicians. Key risks include bruising, swelling, and localized nodule formation, the last of which is more relevant with Ellansé due to its stronger collagen stimulus. Neither product is reversible. Patients with active skin infections, autoimmune conditions, or a history of abnormal scarring require careful pre-treatment assessment.
Q. What does a biostimulator treatment at 4Ever Cheongdam Clinic typically cost?
A. Pricing depends on product selection, volume used, and treatment area. Ellansé is generally priced higher than Juvelook due to its longer duration and dual-mechanism effect. Combination protocols including Teoxane RHA filler or Thermage FLX are priced based on the full treatment plan. Individualized pricing is provided following a structural assessment at consultation.
Q. What does a biostimulator treatment at 4Ever Cheongdam Clinic typically cost?
A. Juvelook is better suited to patients seeking gradual, subtle collagen improvement with a lower risk of overstimulation — particularly those new to biostimulators or with reactive skin. Ellansé is preferred for patients with established volume loss, structural laxity, or a preference for longer-lasting correction from fewer sessions. A consultation assessment of tissue density and volume distribution guides the final recommendation.
Q. Who is the ideal candidate for Ellansé versus Juvelook?
A. Both are biostimulators, but Sculptra (PLLA) produces collagen stimulation without any immediate volumetric effect, relying entirely on the progressive collagen response for its result. Ellansé (PCL) provides immediate volume correction alongside collagen induction. Sculptra is generally preferred when diffuse, global collagen restoration is the objective without need for immediate correction; Ellansé is preferred when both immediate structural support and long-term collagen density are required from a single treatment.
Ready to discuss a treatment plan tailored to your skin?
4ever Cheongdam Clinic offers one-to-one consultations with Dr. Younghan Seo.